key: cord-0782558-d8tqfi8w
authors: Zhao, Yingchi; Kuang, Ming; Zhu, Ling; Li, Junhong; Jia, Zijing; Guo, Xuefei; Wang, Xiangxi; You, Fuping
title: SARS-CoV-2 spike protein interacts with and activates TLR4
date: 2020-12-18
journal: bioRxiv
DOI: 10.1101/2020.12.18.423427
sha: 3c477cb344896567e995507c949f65552218b642
doc_id: 782558
cord_uid: d8tqfi8w

The onset of sepsis is an important feature of COVID19 and a main cause of death. It is unknown how SARS-CoV-2 infection results in viral sepsis in human. We recently found that SARS-CoV-2 provoked an anti-bacterial like response and activation of TLR4 pathway at the very early stage of infection in animal models. This abnormal immune response led to emergency granulopoiesis and sepsis. However, the original trigger of TLR4 signaling by SARS-CoV-2 is unknown. We here identified that the trimeric spike protein of SARS-CoV-2 could bind to TLR4 directly and robustly activate downstream signaling in monocytes and neutrophils. Moreover, specific TLR4 or NFKB inhibitor, or knockout of MyD88 could significantly block IL-1B induction by spike protein. We thus reveal that spike protein of SARS-CoV-2 functions as a potent stimulus causing TLR4 activation and sepsis related abnormal responses.

Accumulating data obtained from numerous cohorts suggested that the main causes 32 of death by COVID-19 include respiratory failure and the onset of sepsis 33 We here identified that the spike protein of SARS-CoV-2 was able to interact with 50 TLR4 directly and activated the production of proinflammatory cytokines. MyD88 and 51 NFKB were required for IL-1B induction by spike protein. The spike protein thus is the 52 original stimulus provoking activation of TLR4 signaling pathway. 53

Previous silico studies predicted that cell surface TLRs, especially TLR4 are most 56 likely to be involved in recognizing molecular patterns, probably spike protein, from 57 and Mukherjee, 2020). Combined with our recent data that TLR4 signaling was 59 activated by SARS-CoV-2 infection, we hypothesized that spike protein of 60 SARS-CoV-2 could activated TLR4 pathway. A recent study showed that trimeric 61 SARS-CoV-2 spike proteins are high quality antigens (Pino et al., 2020) . To this end, 62

we purified the trimeric spike protein (1-1208aa) ( Figure 1A and 1B) , as this form of 63 spike protein presents on the surface of viral particle, which most likely interacted with 64 the proteins on the surface of host cells. The surface plasmon resonance (SPR) assay 65

showed that SARS-CoV-2 spike trimer directly bound to TLR4 with a high affinity 66 ( Figure 1C) . 67

To evaluate its function, we treated THP-1 cell, human monocyte derived from patient 69 with acute monocytic leukemia, with purified spike protein. qRT-PCR analysis showed 70 that IL-1B was robustly induced by spike protein, which was comparable to the positive 71 control LPS (Figure 2A ). To confirm this, we treated cells with an increasing amount of 72 spike protein and found that IL-1B expression was increased in a dose dependent 73 manner ( Figure 2B and 2C). Moreover, IL-6 was also induced by spike protein. As 74 IL-1B induction was much more significant than that of IL-6 ( Figure 2D ), we then 75 chose IL-1B production as a marker of immune activation. More interestingly, the 76 pseudo virus with spike protein was also able to induce IL-1B production ( Figure 2E) . 77

In addition to monocyte, neutrophils are important myeloid cells in sepsis with high 78 expression of TLR4 on their cell surface. We utilized all-trans retinoic acid (ATRA) to 79 treat HL-60 cell, a promyelocytic leukemia cell line, which directed those cells to 80 differentiate into neutrophils. Spike proteins significantly induced IL-1B production in 81 HL-60 cells after ATRA treatment ( Figure 2F and 2G). 82

To gain further insight of the mechanism by with spike protein activates TLR4 in THP-1 cells, so MHV-A59 was not able to infect and enter this human monocyte. 103

To confirm this, we washed those cells after treatment. After washing with PBS, the 104 viral load was significantly decreased, so was the induction of IL-1B (Figure 4) . 105

These data suggested that MHV-A59 could trigger TLR4 signaling probably via 106 spike-TLR4 interaction. symptoms compared to healthy control or asymptomatic patients. Elevated S100A8/9 128 and neutrophils was positive relevant with thrombosis in COVID-19 patients. 129

Together, we could reason that the abnormal early immune responses contributed to 130 unfavorable clinical features of COVID-19 patients. We here found that, before 131 entering the cells, the viral surface spike protein interacted with and activated TLR4. 132

Thus, an anti-bacterial response was initiated at the very early stage of SARS-CoV-2 133 infection. 134

The SPR assay showed that trimeric spike protein interacted with TLR4 directly. 135

However, it is unknown which domain or motif mediates their interaction. We 

Further information and requests for resources and reagents should be directed to and 235 will be fulfilled by the Lead Contact, Fuping You (fupingyou@hsc.pku.edu.cn). 236

This study did not generate new unique reagents. 238

This study did not generate high throughput data. BMDMs (bone-marrow derived macrophages) and peritoneal macrophages was 249 performed as described (Barber, 2009) . 

For the binding affinity assay, purified SARS-CoV-2 S trimer was immobilized onto a 277 CM5 sensor chip surface by using the NHS/EDC method to a level of ~ 700 response 278 units (RUs) using Bia-core 8000 (GE Healthcare) and a PBS running buffer 279 (supplemented with 0.05% Tween-20) was prepared for assay. Serial dilutions of 280 purified TLR4 were injected. The sample flew over the chip at a rate of 20 μl/min for 281 30 s, then the dissociation of the sample was at the same rate for another 30 s. All 282 antibodies were regenerated with Gly 1.5. The response of the sample to the S trimer 283 was recorded at room temperature and the data was analyzed by Bia-core 8000 284

Evaluation Software (GE Healthcare). clarified by centrifuging at 8000 g for 10 min at 4 o C. The virus was collected by an 292 ultracentrifugation at 50000 g for 2 hours (hrs) using Beckman SW41 rotor. The viral 293 pellets were resuspended by FBS free 1640 medium and stored at -80°C before use. 294

The viral particle number was determined using a real time RT-PCR assay to quantify 295 the RNA copies of eGFP. Table S1 . 315

All analyses were repeated at least three times, and a representative experimental 318 result was presented. Two-tailed unpaired Student's t test was used for statistical 319 analysis to determine significant differences when a pair of conditions was compared. 320

Asterisks denote statistical significance (*P < 0.05; **P < 0.01; *** P < 0.001). The 321 data are reported as the mean ± S.D. 322 323

Sting is an endoplasmic reticulum adaptor that facilitates innate 325 immune signaling

Immunoinformatics approach to understand molecular interaction between 328 multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex

Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children

Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New

Clinical characteristics of 113 deceased patients with 337 coronavirus disease 2019: retrospective study

In silico studies on the comparative 339 characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 340 receptor homologs and human TLRs

Clinical Characteristics of Coronavirus Disease

Small molecules inhibit SARS-COV-2 induced aberrant 345 inflammation and viral replication in mice by targeting S100A8/A9-TLR4 axis

SARS-CoV-2 and viral sepsis: observations and hypotheses. The Lancet

Immune response and COVID-19: A mirror image of sepsis

The influence of 355 agents differentiating HL-60 cells toward granulocyte-like cells on their ability to 356 release neutrophil extracellular traps

Trimeric SARS-CoV

Spike proteins produced from CHO-cells in bioreactors are high quality antigens

LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene

Differential immune activation profile of SARS-CoV-2 and 366

SARS-CoV infection in human lung and intestinal cells: Implications for treatment 367 with IFN-beta and IFN inducer

Clinical course and risk factors 369 for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study